Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice.

MLA

Aoki, Ryo, et al. “Commensal Microbe-Derived Acetate Suppresses NAFLD/NASH Development via Hepatic FFAR2 Signalling in Mice.” Microbiome, vol. 9, no. 1, Sept. 2021, p. 188. EBSCOhost, https://doi.org/10.1186/s40168-021-01125-7.

APA

Aoki, R., Onuki, M., Hattori, K., Ito, M., Yamada, T., Kamikado, K., Kim, Y.-G., Nakamoto, N., Kimura, I., Clarke, J. M., Kanai, T., & Hase, K. (2021). Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice. Microbiome, 9(1), 188. https://doi.org/10.1186/s40168-021-01125-7

Chicago

Aoki, Ryo, Masayoshi Onuki, Koya Hattori, Masato Ito, Takahiro Yamada, Kohei Kamikado, Yun-Gi Kim, et al. 2021. “Commensal Microbe-Derived Acetate Suppresses NAFLD/NASH Development via Hepatic FFAR2 Signalling in Mice.” Microbiome 9 (1): 188. doi:10.1186/s40168-021-01125-7.